BioCorRx Valuation
| BICX Stock | USD 0.30 0.06 16.67% |
BioCorRx seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of BioCorRx from analyzing the firm fundamentals such as Shares Owned By Insiders of 58.67 %, return on asset of -2.52, and Current Valuation of 13.9 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that BioCorRx's price fluctuation is out of control at this time. Calculation of the real value of BioCorRx is based on 3 months time horizon. Increasing BioCorRx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioCorRx otc stock is determined by what a typical buyer is willing to pay for full or partial control of BioCorRx. Since BioCorRx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioCorRx OTC Stock. However, BioCorRx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.3 | Real 0.29 | Hype 0.3 | Naive 0.32 |
The intrinsic value of BioCorRx's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioCorRx's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioCorRx helps investors to forecast how BioCorRx otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioCorRx more accurately as focusing exclusively on BioCorRx's fundamentals will not take into account other important factors: BioCorRx Total Value Analysis
BioCorRx is currently forecasted to have valuation of 13.9 M with market capitalization of 11.82 M, debt of 174.16 K, and cash on hands of 81.76 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BioCorRx fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
13.9 M | 11.82 M | 174.16 K | 81.76 K |
BioCorRx Investor Information
About 59.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.69. BioCorRx last dividend was issued on the 22nd of January 2019. The entity had 1:100 split on the 22nd of January 2019. Based on the key measurements obtained from BioCorRx's financial statements, BioCorRx is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.BioCorRx Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BioCorRx has an asset utilization ratio of 5.89 percent. This suggests that the OTC Stock is making $0.0589 for each dollar of assets. An increasing asset utilization means that BioCorRx is more efficient with each dollar of assets it utilizes for everyday operations.BioCorRx Ownership Allocation
The market capitalization of BioCorRx is $11.82 Million. BioCorRx retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.BioCorRx Profitability Analysis
The company reported the previous year's revenue of 48.27 K. Net Loss for the year was (5.21 M) with profit before overhead, payroll, taxes, and interest of 42.39 K.About BioCorRx Valuation
Our relative valuation model uses a comparative analysis of BioCorRx. We calculate exposure to BioCorRx's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioCorRx's related companies.BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.
8 Steps to conduct BioCorRx's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates BioCorRx's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioCorRx's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioCorRx's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioCorRx's revenue streams: Identify BioCorRx's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioCorRx's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioCorRx's growth potential: Evaluate BioCorRx's management, business model, and growth potential.
- Determine BioCorRx's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioCorRx's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BioCorRx Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 6.7 M | |
| Retained Earnings | -70 M |
Additional Tools for BioCorRx OTC Stock Analysis
When running BioCorRx's price analysis, check to measure BioCorRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCorRx is operating at the current time. Most of BioCorRx's value examination focuses on studying past and present price action to predict the probability of BioCorRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCorRx's price. Additionally, you may evaluate how the addition of BioCorRx to your portfolios can decrease your overall portfolio volatility.